SNSS Sunesis Pharmaceuticals Inc

SOUTH SAN FRANCISCO, Calif., March 13 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that Daniel Swisher, Sunesis' Chief Executive Officer and President, will provide a corporate overview at two upcoming investor conferences in March. -- Mr. Swisher will speak at the Cowen and Company 28th Annual Health Care Conference at 8:45 a.m. Eastern Time on Tuesday, March 18, 2008 at the Boston Marriott Copley Place in Boston, Mass. -- On Thursday, March 20, 2008, Mr. Swisher will present at the Lehman Brothers Eleventh Annual Global Healthcare Conference at 12:45 p.m. Eastern Time in Miami, Fla. Interested parties may access a webcast of each the presentations by visiting the Sunesis website at http://ir.sunesis.com/. A replay of the webcasts will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks. About Sunesis Pharmaceuticals Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule therapeutics for oncology and other serious diseases. Sunesis has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. Sunesis is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies. For further information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com/. DATASOURCE: Sunesis Pharmaceuticals, Inc. CONTACT: Investors, Eric Bjerkholt, SVP, Corp. Development & Finance of Sunesis Pharmaceuticals, Inc., +1-650-266-3717; or Media, Karen L. Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both of BCC Partners for Sunesis Pharmaceuticals, Inc. Web site: http://www.sunesis.com/

Copyright